Oncoseer Diagnostics, Inc
OncoSeer Diagnostics, Inc. is a biotech startup using novel multiomic biomarkers and AI modeling across our highly annotated cohort to screen, monitor and diagnose immune related adverse events (irAE's) prior to immune checkpoint inhibitor (ICI) treatments. Our aim is to provide oncologists and pharma an informed way to increase access to ICI's in patients having an early-stage cancer, a prior autoimmune disease, or needing combo ICI treatments where access may be resticted. We are actively seeking technology and industry partnerships with Academic Medical Centers, CRO/Tool/Lab companies, and Pharma.
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
1
1 to 10 range
Open roles
—
no listings
Distinct roles
0
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 1 verified contacts at Oncoseer Diagnostics, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Sign up to unlock all 1 contacts at Oncoseer Diagnostics, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at Oncoseer Diagnostics, Inc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.